L. Seeber

发表

The importance of the patient voice in vaccination and vaccine safety-are we listening?

S. Kochhar, D. Holt, F. Bouder, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Standardization and simplification of vaccination records

S. Kochhar, B. Kisler, W. Maurer, 2014, Expert review of vaccines.

Educating parents about the vaccination status of their children: A user-centered mobile application

P. Obermeier, L. Seeber, B. Rath, 2017, Preventive medicine reports.

Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study

B. Kisler, P. Obermeier, L. Seeber, 2016, Drug Safety.

Incidence, Disease Severity, and Follow-Up of Influenza A/A, A/B, and B/B Virus Dual Infections in Children: A Hospital-Based Digital Surveillance Program

P. Obermeier, L. Seeber, B. Rath, 2022, Viruses.

Enabling Precision Medicine With Digital Case Classification at the Point-of-Care☆

P. Obermeier, L. Seeber, B. Rath, 2016, EBioMedicine.

An Inception Cohort Study Assessing the Role of Pneumococcal and other Bacterial Pathogens in Children with Influenza and ILI and a Clinical Decision Model for Stringent Antibiotic Use

P. Obermeier, L. Seeber, Barbara Rath, 2016, Antiviral therapy.

Human Parechovirus Infections Associated with Seizures and Rash in Infants and Toddlers

X. Chen, P. Obermeier, L. Seeber, 2015, The Pediatric infectious disease journal.

Evaluation of novel second-generation RSV and influenza rapid tests at the point of care.

P. Obermeier, L. Seeber, B. Rath, 2015, Diagnostic microbiology and infectious disease.

Introducing new vaccines in developing countries

S. Kochhar, A. Khamesipour, L. Seeber, 2013, Expert review of vaccines.

Standardization and simplification of vaccination

S. Kochhar, B. Kisler, W. Maurer, 2014 .

Towards a personalised approach to managing influenza infections in infants and children - food for thought and a note on oseltamivir.

X. Chen, P. Obermeier, L. Seeber, 2013, Infectious disorders drug targets.

Acute Disseminated Encephalomyelitis After Human Parechovirus Infection

P. Obermeier, L. Seeber, B. Weschke, 2015, The Pediatric infectious disease journal.

Quantitative Influenza Follow-Up Testing (QIFT)—A Novel Biomarker for the Monitoring of Disease Activity at the Point-of-Care

X. Chen, P. Obermeier, L. Seeber, 2014, PloS one.

A design thinking approach to effective vaccine safety communication.

Christoph Meinel, Ulrich Weinberg, Gabriella Rundblad, 2015, Current drug safety.

Prospective Surveillance of Antiviral Resistance in Hospitalized Infants Less than 12 Months of Age with A(H3N2) Influenza Infection and Treated with Oseltamivir

P. Obermeier, L. Seeber, B. Rath, 2017, Antiviral therapy.